%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
GlaxoSmithKline PLC ADR(GSK) Stock Analysis | Healthcare
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.What is GlaxoSmithKline PLC ADR?
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
The brief on GlaxoSmithKline PLC ADR
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
What is GlaxoSmithKline PLC ADR?
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 93.16B, and a P/E ratio of 14.7x.
Financial Highlights
Investment Breakdown
Analysis
Reward: Moderate (52)Similar stocks to compare
A short list of Drug Manufacturers - General names that are close enough in size to make side-by-side comparison useful.
Openbook research
Articles mentioning GSK
- Read
interactive investor Portfolio Tracker: Track Your ii Investments
How to track an interactive investor portfolio beyond the ii website: export each account's transaction history to CSV, map the columns correctly, and get performance against a benchmark, dividend income, concentration and a Reward and Risk score on every holding.
- Read
Haleon (HLN): What the Fundamentals Show in the Medicine Cabinet
This Haleon stock analysis covers the consumer health group behind Sensodyne and Panadol: FY2025 and H1 2026 figures, margins, dividend and risks.
- Read
GlaxoSmithKline PLC (GSK) Stock Analysis 2026: Vaccines Pipeline, Dividend Cover and Balance Sheet Fundamentals
This GSK stock analysis examines GlaxoSmithKline's Q2 2026 results, vaccines pipeline momentum, dividend cover and balance sheet position following the Nuvalent acquisition. Explore the key financial metrics and risks shaping the investment case in 2026.